Skip to main content

Your search for “Neurological Cancers” returned 135 results

Cancer Drug Could Ease Cognitive Function for Some With Autism

July 25, 2024

An experimental cancer drug could ease cognition for individuals with Rett syndrome, a rare disorder linked to autism, according to new research from the Muotri Lab at the University of California San Diego — a discovery that could lead to therapies for patients with other neurologic conditions.

Study: Two Enzymes Control Liver Damage in NASH

February 6, 2020

After identifying a molecular pathway that allows nonalcoholic steatohepatitis (NASH) to progress into liver cell death, University of California San Diego School of Medicine researchers were able to use these pathways to halt further liver damage.

Controlling Cholesterol in Microglia Alleviates Chronic Pain, Opioid-Free

May 10, 2021

Using a mouse model, researchers discover pivotal role of cholesterol in chronic pain often caused by chemotherapy, and propose novel therapy.

UC San Diego Biological Sciences Professors Elected to National Academy of Sciences

May 9, 2022

School of Biological Sciences neurobiologist Yishi Jin and molecular biologist James T. Kadonaga have been elected to the National Academy of Sciences, one of the highest honors bestowed upon U.S. scientists and engineers.

Study Identifies Cause for Mysterious Cases of Epilepsy in Children

January 12, 2023

An international consortium led by UC San Diego has identified at least some of the genetic drivers of a mysterious form of pediatric epilepsy.

Current Clinical Trial Assessing Potential of CBD in Treatment of Autism

July 14, 2020

Researchers at University of California San Diego School of Medicine are recruiting eligible children between the ages of seven and fourteen years for a Phase III clinical trial to determine whether cannabidiol (CBD) reduces severe behavior problems in children with autism spectrum disorder.

Genetic Variation in Individual Brain Cell Types May Predict Disease Risk

November 14, 2019

Researchers identified non-coding regions of the human genome that control the development and function of four brain cell types and mapped genetic risk variants for psychiatric diseases. They found that risk variants for Alzheimer’s disease were enriched in microglia-specific regulatory elements.

Gene Therapy Finds New Life in an Old Home

November 10, 2022

An international symposium November 17-18, 2022 at UC San Diego will discuss current clinical trials using gene therapy, here and abroad.

Stuck on Flu

November 22, 2013

Researchers at the University of California, San Diego School of Medicine have shown for the first time how influenza A viruses snip through a protective mucus net to both infect respiratory cells and later cut their way out to infect other cells.

More Steps, Moderate Physical Activity Cuts Dementia, Cognitive Impairment Risk

January 25, 2023

UC San Diego Herbert Wertheim School of Public Health and Human Longevity Science study: senior women were less likely to develop mild cognitive impairment or dementia if they did more daily walking and moderate-to-vigorous physical activity.

Category navigation with Social links